EICHOR
● Completed
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Condition: Type 2 Diabetes Mellitus · Sponsor: Novo Nordisk A/S
About this study
The study will look at how well CagriSema helps people lower their blood sugar and body weight. CagriSema is a new weekly medicine that combines two medicines called semaglutide and cagrilintide. CagriSema will be compared to the two medicines semaglutide and cagrilintide, when they are taken alone. CagriSema will also be compared to a "dummy" medicine without any active ingredient. The study will be done in participants who have type 2 diabetes. Participants will take the study medicine together with the current diabetes medicine (metformin with or without an SGLT2 inhibitor).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (405)
| Synexus Clin Res-Birmingham | Birmingham, Alabama, United States | — |
| Univ of Alabama_Birmingham | Birmingham, Alabama, United States | — |
| Cahaba Research | Pelham, Alabama, United States | — |
| Velocity Clinical Research-Phoenix | Phoenix, Arizona, United States | — |
| Synexus Rsch /Cnt Phnx Med C | Phoenix, Arizona, United States | — |
| Arkansas Clinical Research | Little Rock, Arkansas, United States | — |
| Velocity Clinical Res-Banning | Banning, California, United States | — |
| Velocity Clin Res-Chula Vista | Chula Vista, California, United States | — |
| John Muir Physicians Network | Concord, California, United States | — |
| Headlands Research California, LLC | Escondido, California, United States | — |
| Velocity Clin Res Gardena | Gardena, California, United States | — |
| Velocity Clin Res San Diego | La Mesa, California, United States | — |
+ 393 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06065540